Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity

Shuai Jiang, Amy W. Pan, Tzu-Yin Lin, Hongyong Zhang, Michael Malfatti, Ken W Turteltaub, Paul Henderson, Chong-Xian Pan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This rapid report focuses on the pharmacodynamic mechanism of the carboplatin/paclitaxel combination and correlates it with its cytotoxicity. Consistent with the synergistic to additive antitumor activity (the combination index ranging from 0.53 to 0.94), cells exposed to this combination had significantly increased carboplatin-DNA adduct formation when compared to that of carboplatin alone (450 ± 30 versus 320 ± 120 adducts per 108 nucleotides at 2 h, p = 0.004). Removal of paclitaxel increased the repair of carboplatin-DNA adducts: 39.4 versus 33.1 adducts per 108 nucleotides per hour in carboplatin alone (p = 0.021). This rapid report provides the first pharmacodynamics data to support the use of carboplatin/paclitaxel combination in the clinic.

Original languageEnglish (US)
Pages (from-to)2250-2252
Number of pages3
JournalChemical Research in Toxicology
Volume28
Issue number12
DOIs
StatePublished - Dec 21 2015

Fingerprint

Carboplatin
Cytotoxicity
Paclitaxel
Pharmacodynamics
Nucleotides
Repair
carboplatin-DNA adduct

ASJC Scopus subject areas

  • Toxicology

Cite this

Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity. / Jiang, Shuai; Pan, Amy W.; Lin, Tzu-Yin; Zhang, Hongyong; Malfatti, Michael; Turteltaub, Ken W; Henderson, Paul; Pan, Chong-Xian.

In: Chemical Research in Toxicology, Vol. 28, No. 12, 21.12.2015, p. 2250-2252.

Research output: Contribution to journalArticle

Jiang, Shuai ; Pan, Amy W. ; Lin, Tzu-Yin ; Zhang, Hongyong ; Malfatti, Michael ; Turteltaub, Ken W ; Henderson, Paul ; Pan, Chong-Xian. / Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity. In: Chemical Research in Toxicology. 2015 ; Vol. 28, No. 12. pp. 2250-2252.
@article{3108842cfef54e47918f2d5df5e09c1e,
title = "Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity",
abstract = "This rapid report focuses on the pharmacodynamic mechanism of the carboplatin/paclitaxel combination and correlates it with its cytotoxicity. Consistent with the synergistic to additive antitumor activity (the combination index ranging from 0.53 to 0.94), cells exposed to this combination had significantly increased carboplatin-DNA adduct formation when compared to that of carboplatin alone (450 ± 30 versus 320 ± 120 adducts per 108 nucleotides at 2 h, p = 0.004). Removal of paclitaxel increased the repair of carboplatin-DNA adducts: 39.4 versus 33.1 adducts per 108 nucleotides per hour in carboplatin alone (p = 0.021). This rapid report provides the first pharmacodynamics data to support the use of carboplatin/paclitaxel combination in the clinic.",
author = "Shuai Jiang and Pan, {Amy W.} and Tzu-Yin Lin and Hongyong Zhang and Michael Malfatti and Turteltaub, {Ken W} and Paul Henderson and Chong-Xian Pan",
year = "2015",
month = "12",
day = "21",
doi = "10.1021/acs.chemrestox.5b00422",
language = "English (US)",
volume = "28",
pages = "2250--2252",
journal = "Chemical Research in Toxicology",
issn = "0893-228X",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity

AU - Jiang, Shuai

AU - Pan, Amy W.

AU - Lin, Tzu-Yin

AU - Zhang, Hongyong

AU - Malfatti, Michael

AU - Turteltaub, Ken W

AU - Henderson, Paul

AU - Pan, Chong-Xian

PY - 2015/12/21

Y1 - 2015/12/21

N2 - This rapid report focuses on the pharmacodynamic mechanism of the carboplatin/paclitaxel combination and correlates it with its cytotoxicity. Consistent with the synergistic to additive antitumor activity (the combination index ranging from 0.53 to 0.94), cells exposed to this combination had significantly increased carboplatin-DNA adduct formation when compared to that of carboplatin alone (450 ± 30 versus 320 ± 120 adducts per 108 nucleotides at 2 h, p = 0.004). Removal of paclitaxel increased the repair of carboplatin-DNA adducts: 39.4 versus 33.1 adducts per 108 nucleotides per hour in carboplatin alone (p = 0.021). This rapid report provides the first pharmacodynamics data to support the use of carboplatin/paclitaxel combination in the clinic.

AB - This rapid report focuses on the pharmacodynamic mechanism of the carboplatin/paclitaxel combination and correlates it with its cytotoxicity. Consistent with the synergistic to additive antitumor activity (the combination index ranging from 0.53 to 0.94), cells exposed to this combination had significantly increased carboplatin-DNA adduct formation when compared to that of carboplatin alone (450 ± 30 versus 320 ± 120 adducts per 108 nucleotides at 2 h, p = 0.004). Removal of paclitaxel increased the repair of carboplatin-DNA adducts: 39.4 versus 33.1 adducts per 108 nucleotides per hour in carboplatin alone (p = 0.021). This rapid report provides the first pharmacodynamics data to support the use of carboplatin/paclitaxel combination in the clinic.

UR - http://www.scopus.com/inward/record.url?scp=84951281886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951281886&partnerID=8YFLogxK

U2 - 10.1021/acs.chemrestox.5b00422

DO - 10.1021/acs.chemrestox.5b00422

M3 - Article

C2 - 26544157

AN - SCOPUS:84951281886

VL - 28

SP - 2250

EP - 2252

JO - Chemical Research in Toxicology

JF - Chemical Research in Toxicology

SN - 0893-228X

IS - 12

ER -